Enact (ACT) vs Willis Towers Watson Public (WTW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Enact (ACT) has outperformed Willis Towers Watson Public (WTW) over the past year, gaining 29.4% versus a loss of 16.9%. Over five years, ACT leads with a +116.3% price change compared with +17.7% for WTW. Willis Towers Watson Public is the larger company by market cap ($27.66 billion vs $6.41 billion), about 4.3 times the size, while Enact is growing revenue faster (+2.8% vs -2.2%).
On valuation, Enact trades at a lower forward P/E (9.2x vs 13.0x for Willis Towers Watson Public). Enact offers the higher dividend yield (1.87% vs 0.63%). Enact converts more of its revenue into profit, with a net margin of 54.6% versus 16.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACT | WTW |
|---|---|---|
| Share price | $46.64 | $297.86 |
| Market cap | $6.41B | $27.66B |
| 1-day change | +1.79% | +2.47% |
| YTD return | +17.66% | -11.54% |
| 1-year return | +29.38% | -16.93% |
| 5-year return | +116.33% | +17.72% |
| P/E ratio (TTM) | 9.84 | 18.43 |
| Forward P/E | 9.23 | 13.03 |
| EPS (TTM) | $4.74 | $16.16 |
| Dividend yield | 1.87% | 0.63% |
| Annual dividend | $0.87 | $1.88 |
| Revenue (latest FY) | $1.24B | $9.71B |
| Revenue growth (YoY) | +2.83% | -2.24% |
| Net income (latest FY) | $674.24M | $1.60B |
| Operating margin | — | 23.01% |
| Net margin | 54.56% | 16.53% |
| 52-week high | $50.56 | $351.51 |
| 52-week low | $34.64 | $240.61 |
| Distance from 52-week high | -7.75% | -15.26% |
| Analyst consensus | none | buy |
| Avg. price target upside | +7.63% | +25.76% |
| Average volume | 394.00K | 537.08K |
| Shares outstanding | 137.48M | 92.87M |
| Employees | 419 | 48,100 |
| Sector | Finance | Finance |
| Industry | Specialty Insurers | Specialty Insurers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Willis Towers Watson Public is about 4.3 times larger than Enact by market value ($27.66B vs $6.41B).
- ACT has outperformed WTW by 46.3 percentage points over the past year.
- Willis Towers Watson Public trades at a higher earnings multiple (18.4x vs 9.8x trailing P/E).
- Enact offers a meaningfully higher dividend yield (1.87% vs 0.63%).
- Enact is more profitable, keeping 54.6 cents of every revenue dollar as net income versus 16.5 cents for Willis Towers Watson Public.
- Enact grew revenue faster in its latest fiscal year (+2.83% vs -2.24%).
About Enact
ACT stock →Enact Holdings, Inc. operates as a private mortgage insurance company in the United States.
Finance · Specialty Insurers · 419 employees
About Willis Towers Watson Public
WTW stock →Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. The company operates through two segments: Health, Wealth & Career and Risk & Broking.
Finance · Specialty Insurers · 48,100 employees
ACT vs WTW FAQ
Which is bigger, Enact or Willis Towers Watson Public?
Willis Towers Watson Public (WTW) is larger, with a market capitalization of $27.66B compared with $6.41B for Enact (ACT).
Which stock has performed better over the past year, ACT or WTW?
ACT returned +29.38% over the past 12 months, compared with -16.93% for WTW (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ACT or WTW?
ACT has the lower trailing P/E at 9.8, versus 18.4 for WTW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Enact or Willis Towers Watson Public?
Enact has the higher yield at 1.87%, compared with 0.63% for Willis Towers Watson Public.
Are Enact and Willis Towers Watson Public in the same industry?
Yes. Both are classified in the Specialty Insurers industry within the Finance sector.